41 related articles for article (PubMed ID: 9344611)
1. Comparison of mechanisms of angiostasis caused by the anti-inflammatory steroid 5α-tetrahydrocorticosterone versus conventional glucocorticoids.
Abernethie AJ; Gastaldello A; Maltese G; Morgan RA; McInnes KJ; Small GR; Walker BR; Livingstone DE; Hadoke PW; Andrew R
Eur J Pharmacol; 2022 Aug; 929():175111. PubMed ID: 35738450
[TBL] [Abstract][Full Text] [Related]
2. Real-time analysis of gene regulation by glucocorticoid hormones.
McMaster A; Chambers T; Meng QJ; Grundy S; Loudon AS; Donn R; Ray DW
J Endocrinol; 2008 May; 197(2):205-11. PubMed ID: 18434350
[TBL] [Abstract][Full Text] [Related]
3. Induction of the upstream regulatory region of human papillomavirus type 31 by dexamethasone is differentiation dependent.
Bromberg-White JL; Sen E; Alam S; Bodily JM; Meyers C
J Virol; 2003 Oct; 77(20):10975-83. PubMed ID: 14512546
[TBL] [Abstract][Full Text] [Related]
4. Viruses and breast cancer.
Lawson JS; Heng B
Cancers (Basel); 2010 Apr; 2(2):752-72. PubMed ID: 24281093
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus type 16 E6 and E 7 proteins alter NF-kB in cultured cervical epithelial cells and inhibition of NF-kB promotes cell growth and immortalization.
Vandermark ER; Deluca KA; Gardner CR; Marker DF; Schreiner CN; Strickland DA; Wilton KM; Mondal S; Woodworth CD
Virology; 2012 Mar; 425(1):53-60. PubMed ID: 22284893
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the epidermal growth factor receptor by erlotinib prevents immortalization of human cervical cells by Human Papillomavirus type 16.
Woodworth CD; Diefendorf LP; Jette DF; Mohammed A; Moses MA; Searleman SA; Stevens DA; Wilton KM; Mondal S
Virology; 2011 Dec; 421(1):19-27. PubMed ID: 21982220
[TBL] [Abstract][Full Text] [Related]
7. [HPV16 participates in progressive transformation of normal epidermal cells].
Yasumoto S
Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 2):549-61. PubMed ID: 2539784
[TBL] [Abstract][Full Text] [Related]
8. [Steroid substances--regulation of cell proliferation by glucocorticoids].
Nishizawa Y; Matsumoto K
Nihon Rinsho; 1986 Jan; 44(1):115-21. PubMed ID: 3514986
[No Abstract] [Full Text] [Related]
9. Human papillomavirus type 16 E6 and E7 cooperate to increase epidermal growth factor receptor (EGFR) mRNA levels, overcoming mechanisms by which excessive EGFR signaling shortens the life span of normal human keratinocytes.
Akerman GS; Tolleson WH; Brown KL; Zyzak LL; Mourateva E; Engin TS; Basaraba A; Coker AL; Creek KE; Pirisi L
Cancer Res; 2001 May; 61(9):3837-43. PubMed ID: 11325860
[TBL] [Abstract][Full Text] [Related]
10. Retinoic acid resistance at late stages of human papillomavirus type 16-mediated transformation of human keratinocytes arises despite intact retinoid signaling and is due to a loss of sensitivity to transforming growth factor-beta.
Borger DR; Mi Y; Geslani G; Zyzak LL; Batova A; Engin TS; Pirisi L; Creek KE
Virology; 2000 May; 270(2):397-407. PubMed ID: 10792999
[TBL] [Abstract][Full Text] [Related]
11. Retinoic acid inhibition of human papillomavirus type 16-mediated transformation of human keratinocytes.
Khan MA; Jenkins GR; Tolleson WH; Creek KE; Pirisi L
Cancer Res; 1993 Feb; 53(4):905-9. PubMed ID: 8381332
[TBL] [Abstract][Full Text] [Related]
12. Increased sensitivity of human keratinocytes immortalized by human papillomavirus type 16 DNA to growth control by retinoids.
Pirisi L; Batova A; Jenkins GR; Hodam JR; Creek KE
Cancer Res; 1992 Jan; 52(1):187-93. PubMed ID: 1370074
[TBL] [Abstract][Full Text] [Related]
13. Loss of transforming growth factor-beta (TGF-beta) receptor type I mediates TGF-beta resistance in human papillomavirus type 16-transformed human keratinocytes at late stages of in vitro progression.
Mi Y; Borger DR; Fernandes PR; Pirisi L; Creek KE
Virology; 2000 May; 270(2):408-16. PubMed ID: 10793000
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoids stimulate growth of human papillomavirus type 16 (HPV16)-immortalized human keratinocytes and support HPV16-mediated immortalization without affecting the levels of HPV16 E6/E7 mRNA.
Khan MA; Canhoto AJ; Housley PR; Creek KE; Pirisi L
Exp Cell Res; 1997 Oct; 236(1):304-10. PubMed ID: 9344611
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
